Evidence map›Paper›PMID 39012427›Full record

ArticleJournal of nephrology2024

Perspectives of relatives of patients with end-stage kidney disease on kidney sources, commercial kidney donation, and barriers to living kidney donation in Nigeria: a qualitative study.

Manmak Mamven, Oluseyi Ademola Adejumo, Imuetinyan Rashida Edeki, Dapo Sunday Oyedepo, Stanley Chidozie Ngoka, Ibrahim Ummate, Alhaji Abdu, Moses Tari Tuko, Lawrence Adedeji Adeyeye, Umar Loskurima and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Mental health and kidney disease.Nature reviews. Nephrology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Manmak MamvenDepartment of Internal Medicine, University of Abuja, Gwagwalada, Abuja, Nigeria.
Oluseyi Ademola AdejumoDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria. oluseyiadejumo2017@gmail.com.ORCID 0000-0002-0111-2843
Imuetinyan Rashida EdekiDepartment of Internal Medicine, University of Benin Teaching Hospital, Benin City, Edo State, Nigeria.
Dapo Sunday OyedepoDepartment of Internal Medicine, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Stanley Chidozie NgokaDepartment of Internal Medicine, Federal Teaching Hospital, Owerri, Imo State, Nigeria.
Ibrahim UmmateDepartment of Internal Medicine, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Alhaji AbduDepartment of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Bauchi State, Nigeria.
Moses Tari TukoDepartment of Internal Medicine, Federal Medical Centre, Birnin Kebbi, Kebbi State, Nigeria.
Lawrence Adedeji AdeyeyeDepartment of Internal Medicine, Aminu Kano Teaching Hospital, Kano, Kano State, Nigeria.
Umar LoskurimaDepartment of Internal Medicine, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Ayodeji FasaanuDepartment of Internal Medicine, Afe Babalola University Teaching Hospital, Ado Ekiti, Ekiti State, Nigeria.
Nwokedi Chinedu MaduDepartment of Internal Medicine, University of Abuja, Gwagwalada, Abuja, Nigeria.
Dorcas AngbazoNational Assembly Health Service Directorate, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKidney transplantation is the best mode of kidney replacement therapy. However, the shortage of organ donations has been a major challenge globally. Relatives of patients with end-stage kidney disease (ESKD) are potential kidney donors. We explored their perspectives about kidney donation, kidney commercialisation, and barriers to kidney donation.

methodsIn-depth interviews were conducted among 28 relatives of ESKD patients across the six geopolitical zones and Federal Capital Territory of Nigeria. The interview focused on potential sources of kidney donors, kidney commercialisation and barriers to kidney donation. ATLAS.ti version 9.0.22.0 was used for data analysis.

resultsMean age of the study participants was 41.57 ± 14.55 years; 54% were females, 60.7% were married, 93% had tertiary education and 75% were first degree relatives of ESKD patients. There were 7 themes and 28 subthemes generated in this study. The potential sources of kidney donors identified by the study participants included commercial, hospital, family and non-family member donors. While some opined that a family member is the best choice as a kidney donor, others preferred a commercial donor. The majority of those interviewed do not believe that it is wrong to purchase a kidney, and would be willing to do so. Identified factors that promote kidney commercialisation were unwillingness of a family member to donate, having the financial capacity to purchase a kidney, non-fitness of family members to donate. Identified barriers to kidney donation were age, poor health status, polygamy, perceived poor expertise of the medical team, perceived risk of the procedure, parental influence and religious beliefs.

conclusionsThe majority of participants lacked correct information about kidney donation. Implementation of educational program policies and laws regulating and reinforcing ethical principles of kidney donation and transplantation should be ensured.

Indexed as

FamilyKidney Failure, ChronicKidney TransplantationLiving DonorsQualitative ResearchAdultCommerceFemaleHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicMaleMiddle AgedNigeriaTissue and Organ ProcurementYoung AdultBarriersEnd stage kidney diseaseKidney commercialisationKidney donationKidney sources

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.